TDGF1P2 gene

Known as: TDGF1P2, CRIPTO-2, CR-2 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2017
012319832017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
In infected plant cells, closterovirus replicative polyproteins 1a and 1ab drive membrane remodeling and formation of… (More)
Is this relevant?
2017
2017
Susceptibility testing for colistin remains challenging primarily due to its inherent properties. We evaluated colistin stability… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
The present study aimed to investigate probability of a possible endogenous circadian rhythm in human cognitive attribute to… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2013
2013
In eukaryotic virus systems, infection leads to induction of membranous compartments in which replication occurs. Virus-encoded… (More)
  • figure 1
  • figure 2
Is this relevant?
2007
2007
The clinical characteristics and outcome of 15 patients with acute myelogenous leukemia (AML) who experienced relapse at least 5… (More)
Is this relevant?
2004
2004
Summary:The purpose of this evaluation was to investigate the efficacy of high-dose chemotherapy with thiotepa, melphalan, and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1999
1999
Disparity for HLA in unrelated donor bone marrow transplantation (BMT) increases the risk of graft rejection and graft-versus… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
1991
1991
Fifty-four consecutive patients with acute myeloid leukemia (AML) in first relapse presenting at a single institution were… (More)
Is this relevant?
Review
1989
Review
1989
The results of bone marrow autograft (BMAG) in 20 patients with acute leukemia (AL) consecutively treated from October 1985 and… (More)
Is this relevant?
1988
1988
Twenty parkinsonian patients (Hoehn and Yahr scale, I through III) were treated with controlled-release carbidopa-levodopa (CR-2… (More)
Is this relevant?